Each year, satellite meetings are held in conjunction with the Society's Annual Meeting on the Friday before the meeting begins. Satellite meetings are organized by individuals, scientific companies, and scientific groups and must conform to established criteria if they are to be associated with the Society’s Annual Meeting. Biophysical Society approval is required for a meeting to be granted satellite status. Meetings selected as satellites will be expected to enhance the Annual Meeting and serve the interests of its attendees.
Pre-registration is now closed. You may register on-site, at the convention center, before the start time of the meeting.
Drug Discovery for Ion Channels XI
Friday, March 04, 2011, 8:15 AM - 5:15 PM
Sponsored by:
Drug Discovery for Ion Channels XI
Friday, March 04, 2011, 8:15 AM - 5:15 PM
Room 317-318
Co-Chairs:
David Yamane, Molecular Devices, Inc
Chris Mathes, Sophion Biosciences
Peter Tunon, Cellectricon, Inc
Niels Fertig, Nanion Technologies, GMBH
Tentative Agenda
7:30 AM - 8:15 AM
Registration/Introduction
8:15 AM - 9:00 AM - Morning Keynote
Ed McCleskey, Howard Hughes Medical Institute
Acid-sensing Ion Channels: Their Roles in Detecting and Responding to Ischemia
9:00 AM- 9:30 AM
Andrew Southan, BioFocus
Microfluidics-based Multichannel Electrophysiology; Enhanced Support for Hit-to-Lead and Lead Optimisation Studies
9:30 AM- 10:00 AM
Craig McKay, GlaxoSmithKline
Using IonWorks to Compare Changes in the Pharmacology of Mutated TRPA1 Channels
10:00 AM - 10:30 AM
Coffee Break
10:30 AM - 11:00 AM
Dr. Carol Milligan, University of Leeds
Automated Patch Clamp with Primary and Native Cells on the Patchliner
11:00 AM- 11:30 AM
Herman Ng, Allergan Inc.
Evaluation of Voltage-Gated Sodium Channel Inhibitors using Automated Electrophysiology
11:30 AM- 12:00 PM
Said El-Haou, Xention Limited
Development of a Kir3.1/3.4 Automated Screening Assay
12:00 PM - 1:00 PM
Lunch
1:30 PM - 2:15 PM - Afternoon Keynote
Arthur Buzz Brown, ChanTest Corporation
Automated Electrophysiology and Improved Predictivity of Drug Safety and Efficacy
1:45 PM - 2:15 PM
Gail Robertson, University of Wisconsin-Madison
hERG Subunit Detemines IKr Physiology and Pharmacology: Implications for Drug Safety and Screening
2:15 PM- 2:45 PM
Ioana Neagoe, Evotec AG
Characterization of Potential NMDA Receptor Modulators using Dynaflow Pro II and QPatch HTX
2:45 PM- 3:15 PM
David Printzenhoff, Icagen, Inc.
Developing the PatchXpress 7000A for Drug Discovery, Voltage Gated and Ligand Gated Ion Channels
3:15 PM - 3:45 PM
Break
3:45 PM - 4:15 PM
David Hermann, Abbott Laboratories
Modulation of Recombitant P/Q type Calcium Currents by Abeta Globulomer -an Automated Analysis using the Patchliner
4:15 PM- 4:45 PM
Joel Kralj, Harvard University
Fluorescent Optogenetic Probe for Measuring Membrane Potential
5:00 PM - 5:15 PM
Closing Remarks